Attempts to Regulate Drug Pricing Fail During Legislative Chaos

December 31, 2024

Drug Pricing Reforms Stalled Amid Legislative Hurdles and Opposition

In an attempt to address high, out-of-pocket drug prices, Democrats attempted to push through several piece of legislation that would have placed burdensome restrictions on drug manufacturers.


One measure, HB 5350, would have required drug manufacturers to provide drug products to contract pharmacies participating in a 340B program without conditions or limitations, and thereby alter a federal program at the state level. SB 1179, a companion bill introduced by Sen. Singh in the lame duck session, was rammed through Committee, despite opposition from MichBio, BIO, PhRMA, and patient groups, and then garnered full Senate passage only to falter in the House due to that chamber’s inaction.



Legislation to establish a Prescription Drug Affordability Program (PDAB), SB 483, passed the Michigan Senate in 2023 and carried over into 2024 where the bill sat in the House. Such a state-run board would be tasked with conducting cost analysis on prescription drugs and then imposing a reimbursement limit (upper payment limit-UPL) on therapies the PDAB determines are unaffordable to the consumer and/or state health care system. Unfortunately, the legislation would not alter out-of-pockets whatsoever and many patient groups, especially those from the rare disease community, were adamantly opposed. MichBio and BIO slowed the bill by convincing a small group of legislators to oppose the measure. It too died in session when the House couldn’t move it forward.

RECENT ARTICLES

March 28, 2025
Secure Your Spot at The MedTech Conference 2025 with MichBio!
March 28, 2025
Propelling Innovation in CNS Biotherapeutics
March 28, 2025
Dexter Biometry is a contract bioinformatics service, specializing in data analysis, data visualization dashboards and reports, pipeline automation and other digital services for biotech, pharma and academic science. Founded in 2024 to help scientists lacking adequate informatics staff quickly solve a wide variety of data problems, they have leveraged decades of scientific experience to help clients across the country and across scientific disciplines. They have provided cost-effective client solution at a variety of scales, from assistance with manuscript preparation all the way to cloud deployments of containerized pipelines. Early clients have primarily focused on genomics, proteomics and immune oncology, however Dexter Biometry is currently expanding their services into other fields such as virology and agricultural genomics. Built on client relationships in San Diego and Baltimore, Dexter Biometry is looking to build relationships with clients closer to their home in Dexter, MI, where remote services can be augmented with on-site help when needed. Visit their website to learn more: https://dexterbiometry.com/ 
Share by: